全文获取类型
收费全文 | 167223篇 |
免费 | 33643篇 |
国内免费 | 2477篇 |
专业分类
耳鼻咽喉 | 5360篇 |
儿科学 | 5839篇 |
妇产科学 | 2772篇 |
基础医学 | 6136篇 |
口腔科学 | 1976篇 |
临床医学 | 28427篇 |
内科学 | 50893篇 |
皮肤病学 | 7772篇 |
神经病学 | 16893篇 |
特种医学 | 6884篇 |
外科学 | 42312篇 |
综合类 | 334篇 |
现状与发展 | 72篇 |
一般理论 | 13篇 |
预防医学 | 8635篇 |
眼科学 | 3723篇 |
药学 | 2161篇 |
中国医学 | 84篇 |
肿瘤学 | 13057篇 |
出版年
2023年 | 4934篇 |
2022年 | 1295篇 |
2021年 | 3681篇 |
2020年 | 6418篇 |
2019年 | 2753篇 |
2018年 | 7985篇 |
2017年 | 7789篇 |
2016年 | 8945篇 |
2015年 | 9053篇 |
2014年 | 16231篇 |
2013年 | 16567篇 |
2012年 | 7065篇 |
2011年 | 7184篇 |
2010年 | 11215篇 |
2009年 | 15024篇 |
2008年 | 7107篇 |
2007年 | 5335篇 |
2006年 | 7731篇 |
2005年 | 4930篇 |
2004年 | 4106篇 |
2003年 | 2975篇 |
2002年 | 2905篇 |
2001年 | 3873篇 |
2000年 | 3054篇 |
1999年 | 3295篇 |
1998年 | 3796篇 |
1997年 | 3542篇 |
1996年 | 3423篇 |
1995年 | 3276篇 |
1994年 | 1996篇 |
1993年 | 1602篇 |
1992年 | 1377篇 |
1991年 | 1421篇 |
1990年 | 1079篇 |
1989年 | 1188篇 |
1988年 | 1023篇 |
1987年 | 847篇 |
1986年 | 887篇 |
1985年 | 721篇 |
1984年 | 553篇 |
1983年 | 528篇 |
1982年 | 517篇 |
1981年 | 401篇 |
1980年 | 369篇 |
1979年 | 314篇 |
1978年 | 335篇 |
1977年 | 403篇 |
1975年 | 283篇 |
1972年 | 282篇 |
1970年 | 254篇 |
排序方式: 共有10000条查询结果,搜索用时 422 毫秒
61.
Alessia Scarselli Silvia Di Cesare Claudia Capponi Simona Cascioli Maria L. Romiti Gigliola Di Matteo Alessandra Simonetti Paolo Palma Andrea Finocchi Barbarella Lucarelli Rita M. Pinto Ippolita Rana Giuseppe Palumbo Maurizio Caniglia Paolo Rossi Rita Carsetti Caterina Cancrini Alessandro Aiuti 《Journal of clinical immunology》2015,35(4):373-383
62.
63.
64.
Robert J. Motzer MD Bernard Escudier MD Saby George MD Hans J. Hammers MD PhD Sandhya Srinivas MD Scott S. Tykodi MD PhD Jeffrey A. Sosman MD Elizabeth R. Plimack MD Giuseppe Procopio MD David F. McDermott MD Daniel Castellano MD Toni K. Choueiri MD Frede Donskov MD PhD Howard Gurney MD Stéphane Oudard MD Martin Richardet MD PhD Katriina Peltola MD PhD Ajjai S. Alva MD Michael Carducci MD John Wagstaff MD Christine Chevreau MD Satoshi Fukasawa MD Yoshihiko Tomita MD PhD Thomas C. Gauler MD Christian K. Kollmannsberger MD Fabio A. Schutz PhD James Larkin MD PhD David Cella PhD M. Brent McHenry PhD Shruti Shally Saggi BEng Nizar M. Tannir MD 《Cancer》2020,126(18):4156-4167
65.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974
66.
67.
68.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
69.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
70.